Published in J Virol on March 01, 1989
Initiation of encephalomyocarditis virus RNA translation: the authentic initiation site is not selected by a scanning mechanism. EMBO J (1990) 3.92
RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev (1996) 3.36
Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies. J Virol (1991) 2.75
Template-switching during DNA synthesis by Thermus aquaticus DNA polymerase I. Nucleic Acids Res (1995) 2.46
Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19
Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J (1994) 2.13
In vitro mutational analysis of cis-acting RNA translational elements within the poliovirus type 2 5' untranslated region. J Virol (1991) 2.08
Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA. J Virol (1992) 1.99
5' and 3' untranslated regions of pestivirus genome: primary and secondary structure analyses. Nucleic Acids Res (1993) 1.86
Dual initiation sites of protein synthesis on foot-and-mouth disease virus RNA are selected following internal entry and scanning of ribosomes in vivo. EMBO J (1992) 1.60
Generation and analysis of nonhomologous RNA-RNA recombinants in brome mosaic virus: sequence complementarities at crossover sites. J Virol (1991) 1.48
Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol (1990) 1.45
Genetic recombination in brome mosaic virus: effect of sequence and replication of RNA on accumulation of recombinants. J Virol (1992) 1.42
The sequence context of the initiation codon in the encephalomyocarditis virus leader modulates efficiency of internal translation initiation. J Virol (1992) 1.33
Effect of mutations downstream of the internal ribosome entry site on initiation of poliovirus protein synthesis. J Virol (1994) 1.28
SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathog (2011) 1.17
Genetic variation in vivo and proposed functional domains of the 5' noncoding region of poliovirus RNA. J Virol (1992) 1.17
Interaction of translation initiation factor eIF4B with the poliovirus internal ribosome entry site. J Virol (2002) 1.00
Mechanism of initiation site selection promoted by the human rhinovirus 2 internal ribosome entry site. J Virol (2010) 0.81
Construction of regulatable picornavirus IRESes as a test of current models of the mechanism of internal translation initiation. RNA (2001) 0.79
Generation of Recombinant Polioviruses Harboring RNA Affinity Tags in the 5' and 3' Noncoding Regions of Genomic RNAs. Viruses (2016) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Improved estimation of secondary structure in ribonucleic acids. Nat New Biol (1973) 46.33
Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature (1988) 19.07
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell (1979) 12.83
Cloned poliovirus complementary DNA is infectious in mammalian cells. Science (1981) 12.50
Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50
Polyadenylic acid at the 3'-terminus of poliovirus RNA. Proc Natl Acad Sci U S A (1972) 5.42
The mechanism of RNA recombination in poliovirus. Cell (1986) 5.35
Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol Cell Biol (1985) 4.94
Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol (1986) 4.91
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res (1984) 4.19
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome. Proc Natl Acad Sci U S A (1986) 3.23
Further characterization of Sendai virus DI-RNAs: a model for their generation. Cell (1977) 3.10
Genome-linked proteins of viruses. Cell (1982) 3.02
Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5'-noncoding region of the viral RNA. Virology (1986) 2.95
Origin and replication of defective interfering particles. Curr Top Microbiol Immunol (1981) 2.69
Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol (1986) 2.63
Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55
Antigen chimaeras of poliovirus as potential new vaccines. Nature (1988) 2.38
In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26
Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07
The primary structure of crossover regions of intertypic poliovirus recombinants: a model of recombination between RNA genomes. Virology (1986) 1.98
A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. Proc Natl Acad Sci U S A (1986) 1.90
Studies on the recombination between RNA genomes of poliovirus: the primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants. Virology (1987) 1.81
An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology (1986) 1.61
A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol (1988) 1.58
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs. J Virol (1984) 1.40
Construction of poliovirus intertypic recombinants by use of cDNA. J Virol (1986) 1.38
Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain. Virology (1985) 1.35
Strategy for construction of live picornavirus vaccines. Vaccine (1988) 1.03
Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14
Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol (1999) 3.47
The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J (1990) 3.31
Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol (1989) 2.98
Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87
Regulation of yAP-1 nuclear localization in response to oxidative stress. EMBO J (1997) 2.84
Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res (1994) 2.81
Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol (1986) 2.63
Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55
Complete nucleotide sequence of the genome of coxsackievirus B1. Virology (1987) 2.49
In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26
Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19
Antigenic variation and resistance to neutralization in poliovirus type 1. Science (1985) 2.19
Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14
In vitro construction of poliovirus defective interfering particles. J Virol (1989) 2.10
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07
The genome of poliovirus is an exceptional eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol (1976) 1.99
The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded. Virology (1978) 1.89
Defective interfering particles of poliovirus: mapping of the deletion and evidence that the deletions in the genomes of DI(1), (2) and (3) are located in the same region. J Mol Biol (1979) 1.87
Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol (1999) 1.86
Regulation of the yeast Yap1p nuclear export signal is mediated by redox signal-induced reversible disulfide bond formation. Mol Cell Biol (2001) 1.79
Transformation-defective mutants of Rous sarcoma virus with longer sizes of genome RNA and their highly frequent occurrences. J Virol (1979) 1.78
Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A (1991) 1.77
Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol (1980) 1.71
Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature (1988) 1.71
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70
Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particles RNAs, and fingerprint of the poliovirus type 3 genome. J Gen Virol (1979) 1.68
Psychological effects of aromatherapy on chronic hemodialysis patients. Psychiatry Clin Neurosci (2000) 1.65
Determination of functional domains in polypyrimidine-tract-binding protein. Biochem J (1998) 1.63
Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X. J Virol (1997) 1.61
An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology (1986) 1.61
Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp Cell Res (1997) 1.60
Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J Virol (1998) 1.59
A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol (1988) 1.58
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia (2006) 1.56
Nucleotide sequences important for translation initiation of enterovirus RNA. J Virol (1991) 1.53
Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest (1998) 1.48
Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology (1998) 1.47
Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J Biol Chem (1994) 1.47
Crm1 (XpoI) dependent nuclear export of the budding yeast transcription factor yAP-1 is sensitive to oxidative stress. Genes Cells (1998) 1.43
Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther (1993) 1.42
Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors. Virology (1997) 1.40
A second group of hepatitis C viruses. Virus Genes (1991) 1.39
Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene. Gastroenterology (2001) 1.39
Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology (1997) 1.36
Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain. Virology (1985) 1.35
Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage. J Virol (1999) 1.33
Nucleotide sequence of the gene encoding the serotype-specific antigen of human (Wa) rotavirus: comparison with the homologous genes from simian SA11 and UK bovine rotaviruses. J Virol (1984) 1.32
Urinary bisphenol A and plasma hormone concentrations in male workers exposed to bisphenol A diglycidyl ether and mixed organic solvents. Occup Environ Med (2002) 1.26
Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase. J Mol Biol (1989) 1.23
Comparative sequence analysis of the 5'terminal noncoding regions of poliovirus vaccine strain Sabin 1, Sabin 2, and Sabin 3 genomes. Virology (1981) 1.23
Adrenoleukodystrophy: studies of the phenotype, genetics and biochemistry. Johns Hopkins Med J (1980) 1.23
Restriction map of double-stranded DNA copy synthesized from poliovirus Sabin 1 RNA. J Biochem (1982) 1.18
Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis. Virology (1993) 1.17
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16
Nucleotide sequence of human rotavirus genome segment 10, an RNA encoding a glycosylated virus protein. J Virol (1984) 1.16
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci U S A (1998) 1.15
Down-regulation of translation driven by hepatitis C virus internal ribosomal entry site by the 3' untranslated region of RNA. Arch Virol (2001) 1.15
Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J Virol (1997) 1.15
Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem (1992) 1.14
Simultaneous induction of an HDL receptor protein (SR-BI) and the selective uptake of HDL-cholesteryl esters in a physiologically relevant steroidogenic cell model. J Lipid Res (1998) 1.11
A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J Virol (1992) 1.11
Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet (2001) 1.10
The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res (1989) 1.10
Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis. Arch Virol (1994) 1.09
Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood (1998) 1.09
Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J Virol (1999) 1.09
Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch Virol (1995) 1.08
High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients. Biochem Biophys Res Commun (1978) 1.05
[Proposal of a standard method for clinical evaluation of antimicrobial agents in prostatitis--specifications of patients and criteria for evaluation of clinical efficacy]. Hinyokika Kiyo (1989) 1.04
Host range of poliovirus is restricted to simians because of a rapid sequence change of the poliovirus receptor gene during evolution. Arch Virol (2003) 1.03
Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J Gen Virol (1999) 1.03
Molecular cloning and complete nucleotide sequence of the genome of Japanese encephalitis virus Beijing-1 strain. Virus Genes (1988) 1.02
Identification of a new element for RNA replication within the internal ribosome entry site of poliovirus RNA. J Gen Virol (1999) 1.02
Poliovirus infection of established human blood cell lines: relationship between the differentiation stage and susceptibility of cell killing. Virology (1987) 1.02
Expression and function of an early activation marker restricted to human B cells. J Immunol (1986) 1.00
Possible point mutation sites in LSc, 2ab poliovirus RNA and a protein covalently linked to the 5'-terminus. J Gen Virol (1979) 1.00
Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril (1998) 1.00
Expression and microvillar localization of scavenger receptor, class B, type I (a high density lipoprotein receptor) in luteinized and hormone-desensitized rat ovarian models. Endocrinology (1998) 1.00
Nuclear import of the yeast AP-1-like transcription factor Yap1p is mediated by transport receptor Pse1p, and this import step is not affected by oxidative stress. J Biol Chem (2001) 0.99
B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes. J Immunol (1986) 0.99
Sonographic characteristics of massive ovarian edema. Ultrasound Obstet Gynecol (2000) 0.99
The comet assay in eight mouse organs: results with 24 azo compounds. Mutat Res (2000) 0.98
Recent insights into poliovirus pathogenesis. Trends Microbiol (2001) 0.98
Hemorrhage into a simple liver cyst: diagnostic implications of a recent case. J Gastroenterol (1997) 0.98
Structural, magnetic and electronic state characterization of L1 0-type ordered FeNi alloy extracted from a natural meteorite. J Phys Condens Matter (2014) 0.97